Cargando…

Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1

SIMPLE SUMMARY: Localized rectal cancer is currently managed with neoadjuvant therapy before surgery which includes concurrent chemoradiation therapy alone or a total neoadjuvant therapy approach which involves chemotherapy and concurrent chemoradiation sequentially. These strategies are changing, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tayshetye, Pritam, Friday, Andrew J., Omstead, Ashten N., Verma, Tanvi, Miller, Stacey, Zheng, Ping, Jani, Prashant, Zaidi, Ali, Finley, Gene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818440/ https://www.ncbi.nlm.nih.gov/pubmed/36612271 http://dx.doi.org/10.3390/cancers15010276

Ejemplares similares

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature
por: Tayshetye, Pritam, et al.
Publicado: (2020)

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
por: Zaidi, Ali H., et al.
Publicado: (2021)

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma
por: Matsui, Daisuke, et al.
Publicado: (2016)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
por: Kim, H. R., et al.
Publicado: (2000)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
por: Conde-Muíño, Raquel, et al.
Publicado: (2015)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence
por: Ayazi, Shahin, et al.
Publicado: (2019)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

Rectal tumor fragmentation as a response pattern following chemoradiation
por: Mills, Matthew N., et al.
Publicado: (2022)

Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management
por: Ayazi, Shahin, et al.
Publicado: (2019)

Influence of chemoradiation on the immune microenvironment of cervical cancer patients
por: Herter, J. M., et al.
Publicado: (2022)

High yield reproducible rat model recapitulating human Barrett’s carcinogenesis
por: Matsui, Daisuke, et al.
Publicado: (2017)

Measurement of outflow resistance imposed by magnetic sphincter augmentation: defining normal values and clinical implication
por: Ayazi, Shahin, et al.
Publicado: (2020)

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
por: Verstraete, M, et al.
Publicado: (2015)

Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer
por: Bitterman, Danielle S., et al.
Publicado: (2015)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
por: Lombardi, Raffaele, et al.
Publicado: (2009)

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
por: Restivo, Angelo, et al.
Publicado: (2015)

Predictive clinical model of tumor response after chemoradiation in rectal cancer
por: Santos, Marisa D, et al.
Publicado: (2017)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer
por: Lee, Yong Joon, et al.
Publicado: (2018)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2021)

Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer
por: Smithson, Mary, et al.
Publicado: (2022)

Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
por: Chen, Junbing, et al.
Publicado: (2022)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
por: Jensen, Garrett L., et al.
Publicado: (2023)

Multi-scale modeling of macrophage—T cell interactions within the tumor microenvironment
por: Cess, Colin G., et al.
Publicado: (2020)

Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response
por: Lee, Tae Hoon, et al.
Publicado: (2023)

The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year
por: Yoo, Ri Na, et al.
Publicado: (2023)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Interesting and unusual clinical presentations in leprosy at a referral center
por: Tayshetye, Pritam U., et al.
Publicado: (2013)

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients
por: Kye, Bong-Hyeon, et al.
Publicado: (2016)

What the radiologist needs to know about restaging of rectal carcinoma after chemoradiation therapy
por: Nazar, ME, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qhj66tt1rlf7c600mo1dcmt3ht